Skip to content
‹ Back to IndustriesHealthcare

How One Company Expects to Dominate Corporate Lunches

In India, the foodtech industry on fire right now—and Swiggy has become a major player. To stay relevant, the foodtech innovator is experimenting with B2B segment services by launching a pilot program for B2B food aggregation. Swiggy Café started three months ago, is digitizing corporate cafeterias and being tested at two locations in Bengaluru representing the…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI in a free MarketScale workspace. Qualifying companies also get one professional video edit a month. No credit card.

Start free

In India, the foodtech industry on fire right now—and Swiggy has become a major player. To stay relevant, the foodtech innovator is experimenting with B2B segment services by launching a pilot program for B2B food aggregation.

Swiggy Café started three months ago, is digitizing corporate cafeterias and being tested at two locations in Bengaluru representing the corporate sector.

Swiggy Café, reportedly still in development and looking to use their program as part of an overall larger business plan, gives users an app to order lunch from certain cafeterias in corporate hubs and receive notification when it is ready.

The idea is to cut wait times and improve efficiency during the lunch rush. The service is currently being used a few hundred times per day. Swiggy’s larger service, which offers food delivery, is currently handling more than 650,000 orders per day.

According to TechCrunch.com, the B2B food delivery arena is one of the largest untapped areas in the corporate world. While consumers have services such as Amazon and Instacart vying for our business, one area—the food and ingredient delivery for businesses—is still greatly underserved. This market is attention and capital starved and the industry is far behind where it could be, as result. One example is the food-preparation facilities and the challenges they face getting the ingredients to cook the food that consumers crave.

Another company ripe for the B2B market are those like Accomplice, whose apps coordinate ridesharing and food ordering. Already used in the B2C market, businesses also make a good market for these aggregator apps. They allow employees to save money for their employers and companies to save money for their clients. This is particularly true in situations in which travel and food expenses are reimbursed, as it provides a single platform form which to do business in a more cost-effective and time-efficient manner.

Accomplice Founder and CEO Hani Samaan wants to expand his presence throughout the U.S. and outside of America’s borders. Meanwhile, great news is reported for Swiggy as well—spending on food and business in the B2B space alone is estimated to reach $14 billion in India in 2018 with the sector growing at 15 percent per annum.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0. No credit card. Company confirmation required.

More Healthcare Insights

Medicare will pay up to $137.53 per case in 2027 for BriefCase‑Triage

Medicare will pay up to $137.53 per case in 2027 for BriefCase‑Triage

Radiology Business reported Medicare will pay a maximum of $137.53 per case in 2027 for BriefCase-Triage. Holland & Knight said hospitals will be eligible for NTAP reimbursement for use of Aidoc’s CARE Body CT Multi-Triage beginning Oct. 1, 2026, with supplemental payments continuing for three years.

  • 01Radiology Business reported Medicare will pay a maximum of $137.53 per case in 2027 for BriefCase-Triage.
  • 02Holland & Knight said CMS approved an NTAP designation for Aidoc’s CARE Body CT Multi-Triage, with hospitals eligible for NTAP reimbursement beginning Oct. 1, 2026, with supplemental payments continuing for three years.

Sep 23, 2026

Blair Health raises CAD $4.24M to expand its LLM-guided specialty care workflows

Blair Health raises CAD $4.24M to expand its LLM-guided specialty care workflows

Blair Health raised CAD $4.24 million in a pre-seed round, according to Fierce Healthcare. It plans to expand protocol-driven virtual specialty care across Canada and the U.S.

  • 01Blair Health raised CAD $4.24 million in pre-seed funding.
  • 02Qualified Health positions its AI platform around safety and governance, including clinician oversight, auditability and traceability, according to Fierce Healthcare.

Sep 23, 2026

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512